Assessing visual function in clinical practice

Ophthalmology Clinics of North America

Volumn 13, Issue 3, 2000, Pages 361-382

  Spry, Paul G D ^a,c   Johnson, Chris A ^b  

^a DEVERS EYE INSTITUTE   (United States)

^b Oregon Lions Anderson Chenoweth Ross Vision Research Center   (United States)

^c DEVERS EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFACT; AUTOMATION; CLINICAL PRACTICE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUMINANCE; PERIMETRY; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW; VISUAL FIELD DEFECT; VISUAL SYSTEM FUNCTION;

EID: 0033761378     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(05)70200-5     Document Type: Article

References (115)

1. S cone pathway sensitivity loss in ocular hypertension and early glaucoma has nerve fibre bundle pattern
2. Diffuse and localized nerve fiber loss in glaucoma
3. Visual field and retinal nerve fiber layer comparisons in glaucoma
4. Retinal nerve fiber layer photography in glaucoma
5. The Advanced Glaucoma Intervention Study (AGIS): I. Study design and methods and base-line characteristics of study patients
6. Advanced Glaucoma Intervention Study: 2. Visual field test scoring and reliability
7. A simple grating test for contrast sensitivity: Preliminary results indicate value in screening for glaucoma
8. Diffuse visual field loss and glaucoma
9. Glaucoma Hemifield Test. Automated visual field evaluation
10. Frequency distribution of early glaucomatous visual field defects
11. Static perimetry: Accuracy and fluctuations
12. A new generation of algorithms for computerized threshold perimetry, SITA
13. The normal visual field on the Humphrey field analyzer
14. Lateral geniculate nucleus in glaucoma
15. The use of visual field indices in detecting changes in the visual field in glaucoma
16. Intratest variability in conventional and high-pass resolution perimetry
17. Comparison of conventional and high-pass resolution perimetry in a prospective study of patients with glaucoma and healthy controls
18. Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects
19. Repeatable diffuse visual field loss in open-angle glaucoma
20. Characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma
21. Physiology, morphology and spatial densities of identified ganglion cell types in primate retina
22. The 'blue-on' opponent pathway in primate retina originates from a distinct bistratified ganglion cell type
23. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus
24. Isolation of short wavelength sensitive mechanisms in normal and glaucomatous visual regions
25. Fixational instability during perimetry and the blindspot monitor
26. The early visual field defect in glaucoma and the significance of nasal steps
27. Diffuse visual field loss in chronic open-angle and low-tension glaucoma
28. Psychophysics 1. Discrimination and detection
29. Functional characteristics of blue-on-yellow perimetric thresholds in glaucoma
30. Analysis of visual field progression in glaucoma
31. Differential light threshold. Short- and long-term fluctuation in patients with glaucoma, normal controls, and patients with suspected glaucoma
32. Evaluation of FAST-PAC, a new strategy for threshold estimation with the Humphrey Field Analyzer, in a glaucomatous population
33. Use of blue-on-yellow perimetry to demonstrate quadrantanopia in multiple sclerosis
34. The onset and evolution of glaucomatous visual field defects
35. Progressive visual field defects from experimental glaucoma: Measurements with white and coloured stimuli
36. Ganglion cell losses underlying visual field defects from experimental glaucoma
37. The Humphrey field analyzer, construction and concepts
38. Test-retest variability in glaucomatous visual fields
39. Extended empirical statistical package for evaluation of single and multiple fields in glaucoma: Statpac 2
40. Normal variability of static perimetric threshold values across the central visual field
41. Regression analysis of the central visual field in chronic glaucoma cases. A follow-up study using automatic perimetry
42. Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema
43. Fatigue effects during a single session of automated static threshold perimetry
44. Evaluation of visual function
45. Perimetry and visual field testing
46. Selective versus non-selective losses in glaucoma
47. Fatigue effects in automated perimetry
48. Frequency doubling technology using a 24-2 stimulus presentation pattern
49. Principles and techniques of examination of the visual sensory system
50. The Glenn A. Fry Award Lecture. Early losses of visual function in glaucoma
51. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss
52. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry
53. Evidence for a neural basis of age-related visual field loss in normal observers
54. Age-related changes in the central visual field for short-wavelength-sensitive pathways
55. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results
56. Properties of staircase procedures for estimating thresholds in automated perimetry
57. A prospective three-year study of response properties of normal subjects and patients during automated perimetry
58. Screening for glaucomatous visual field loss with frequency-doubling perimetry
59. On the definition of age-related norms for visual function testing
60. Morphometry of the human lamina cribrosa surface
61. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment
62. Estimating progression of visual field loss in glaucoma
63. Frequency doubling in visual responses
64. Short-wavelength automated perimetry in neuro-ophthalmologic disorders
65. Peripheral nasal field defects
66. Early glaucomatous visual field defects and their significance to clinical ophthalmology
67. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy
68. Performance of non-linear visual units in ocular hypertension and glaucoma
69. Evidence that blue-on cells are part of the third geniculocortical pathway in primates
70. Selective cell death in glaucoma: Does it really occur?
71. The influence of age-related cataract on blue-on-yellow perimetry
72. Analysis of visual dysfunctions in HIV-positive patients without retinitis
73. Response properties of normal observers and patients during automated perimetry
74. Vernier thresholds and alignment bias in control, suspect and glaucomatous eyes
75. Neuropsychological impairment-associated visual field deficits in HIV infection
76. Correlation of functional and structural measurements in eyes suspected of having glaucoma
77. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage
78. Optic nerve damage in human glaucoma: III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy
79. Optic nerve damage in human glaucoma: II. The site of injury and susceptibility to damage
80. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers
81. The aging lens: In vivo assessment of light absorption in 84 human eyes
82. Optimum parameters for short-wavelength automated perimetry
83. Short-wavelength automated perimetry without lens density testing
84. Short-wavelength color visual fields in glaucoma suspects at risk
85. Color perimetry for assessment of primary open-angle glaucoma
86. Progressive color visual field loss in glaucoma
87. Acquired dyschromatopsia in glaucoma
88. Pseudo-loss of fixation in automated perimetry
89. Probability maps for evaluating automated visual fields
90. Cat and monkey retinal ganlion cells and their functional roles
91. Analysis of progressive change in automated visual fields in glaucoma
92. Evaluation of glaucomatous visual field progression using a computer model and a simulated dataset
93. The peripheral visual field in glaucoma: Reevaluation in the age of automated perimetry
94. Peripheral visual field testing by automated kinetic perimetry in glaucoma
95. Observations on spatial-frequency doubling
96. Specific deficits of flicker sensitivity in glaucoma and ocular hypertension
97. A rapid technique to assess the resting states of the others and other threshold phenomena: The modified binary search (MOBS)
98. A new look at threshold estimation algorithms for automated static perimetry
99. How often do patients need visual field tests?
100. Glaucomatous cupping of the human optic disk: A neuro-histologic study
101. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli
102. Peripheral nasal field defects in glaucoma
103. Increased scatter of responses as a precursor of visual field changes in glaucoma
104. Is conventional automated perimetry sufficient for evaluation of the nasal step in glaucoma? High spatial resolution perimetry can identify scotomas not apparent on conventional Humphrey testing
105. Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma
106. Serial examination of the normal visual field using Octopus automated projection perimetry: Evidence for a learning effect
107. Lens rim artifact in automated threshold perimetry